December 19, 2013
Video
William Kevin Kelly, DO, professor of medical oncology and urology, Thomas Jefferson University, discusses the possibility of preselecting which castration-resistant prostate cancer (CRPC) patients will be sensitive to chemotherapy or hormone therapy.
November 19, 2013
Video
William Kevin Kelly, DO, discusses the role of chemotherapy in castration-resistant prostate cancer.